세계의 동물용 백신 시장 : 동물 유형별, 기술별, 투여 경로별, 유통 채널별 - 예측(2025-2030년)

The Veterinary Vaccines Market was valued at USD 9.82 billion in 2023, expected to reach USD 10.40 billion in 2024, and is projected to grow at a CAGR of 6.43%, to USD 15.19 billion by 2030.

The veterinary vaccines market encompasses the development and production of vaccines tailored for animals to prevent diseases, enhance health, and improve productivity across livestock and companion animals. These vaccines are essential for preventing outbreaks of zoonotic diseases, reducing animal mortality, and minimizing economic losses in the agricultural sector. Their application covers livestock, such as cattle and poultry, and extends to pets. This diverse market is primarily driven by factors like rising animal healthcare expenditure, an increase in livestock population, and growing demand for animal-derived food products. Additionally, the increased pet adoption rates fuel the demand for companion animal vaccines. Key growth influencers include advancements in biotechnology, which have propelled the development of novel vaccines, and governmental initiatives supporting animal health. Potential opportunities lie in expanding services in under-researched regions like Asia-Pacific and Africa, where livestock farming is burgeoning. Exploring partnerships with local veterinary clinics for tailored vaccination strategies can further enhance market penetration. However, challenges such as high costs of vaccine storage and transportation, regulatory hurdles, and vaccine hesitancy among livestock owners limit growth. Additionally, there's a widespread lack of awareness regarding animal health practices, particularly in developing regions. In terms of innovation, developing vaccines with broad-spectrum capabilities and those offering long-lasting immunity can be game-changing. Biotechnology innovations such as DNA and recombinant vaccines present lucrative R&D areas. Despite the promising growth trajectory, the market shows moderate competitive intensity with notable players investing heavily in R&D and mergers/acquisitions to augment product lines and market reach. Addressing limitations via strategic educational initiatives and enhancing distribution networks are pivotal for sustained growth. Businesses should focus on regulatory compliance to avoid potential pitfalls and support efforts to improve awareness about animal health and vaccination benefits.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Vaccines Market

The Veterinary Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Rising incidence of chronic diseases and accidental injuries in animals
  • Government initiatives for immunization of veterinary animals
• Market Restraints
  • High cost associated with development, storage, and handling of vaccines
• Market Opportunities
  • Shift from live attenuated vaccines to DNA vaccines
  • Rising investments and R&D for development of novel veterinary vaccines
• Market Challenges
  • Concerns associated with stringent regulatory compliance

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Vaccines Market

A detailed market share analysis in the Veterinary Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Vaccines Market

A strategic analysis of the Veterinary Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Animal Type, market is studied across Aquaculture, Companion Animals, and Livestock. The Livestock is further studied across Bovine, Porcine, Poultry, and Small Ruminants.
• Based on Technology, market is studied across Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines.
• Based on Route of Administration, market is studied across Intravenous, Nasal, and Oral.
• Based on Distribution Channel, market is studied across Hospitals & Clinics and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Rising incidence of chronic diseases and accidental injuries in animals
    • 5.1.1.3. Government initiatives for immunization of veterinary animals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with development, storage, and handling of vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
    • 5.1.3.2. Rising investments and R&D for development of novel veterinary vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with stringent regulatory compliance
• 5.2. Market Segmentation Analysis
  • 5.2.1. Animal Type: Rising usage of vaccines for disease prevention in livestock animals
  • 5.2.2. Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
  • 5.2.3. Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
  • 5.2.4. Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Vaccines Market, by Animal Type

• 6.1. Introduction
• 6.2. Aquaculture
• 6.3. Companion Animals
• 6.4. Livestock
  • 6.4.1. Bovine
  • 6.4.2. Porcine
  • 6.4.3. Poultry
  • 6.4.4. Small Ruminants

7. Veterinary Vaccines Market, by Technology

• 7.1. Introduction
• 7.2. Inactivated Vaccines
• 7.3. Live Attenuated Vaccines
• 7.4. Recombinant Vaccines
• 7.5. Toxoid Vaccines

8. Veterinary Vaccines Market, by Route of Administration

• 8.1. Introduction
• 8.2. Intravenous
• 8.3. Nasal
• 8.4. Oral

9. Veterinary Vaccines Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Retail Pharmacies

10. Americas Veterinary Vaccines Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Vaccines Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Vaccines Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Merck Animal Health launches 3-in-one swine vaccine
  • 13.3.2. IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
  • 13.3.3. Merck Animal Health to Acquire Venc
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Addison Biological Laboratory Inc.
• 2. Aptimmune Biologics, Inc
• 3. Bimeda Inc.
• 4. Biokema SA
• 5. Boehringer Ingelheim International GmbH
• 6. Brilliant Bio Pharma Private Limited
• 7. Ceva Sante Animale
• 8. China Animal Husbandry Industry Co., Ltd
• 9. Covetrus, Inc.
• 10. Elanco Animal Health Incorporated
• 11. Endovac Animal Health.
• 12. Hester Biosciences Limited
• 13. HIPRA, S.A
• 14. Indian Immunologicals Ltd.
• 15. Kemin Industries, Inc.
• 16. Kyoritsuseiyaku Corporation
• 17. Laboratoire LCV
• 18. Meiji Holdings Co., Ltd.
• 19. Merck & Co., Inc
• 20. Neogen Corporation
• 21. Norbrook Laboratories Limited
• 22. Phibro Animal Health Corporation
• 23. Saiba Animal Health AG
• 24. Sumitomo Pharma Animal Health Co., Ltd.
• 25. Torigen Pharmaceuticals Inc.
• 26. Vaxxinova International BV
• 27. Virbac SA
• 28. YEBIO BIOENGINEERING CO., LTD OF QINGDAO
• 29. Zoetis Inc.